Preventing brain atrophy should be the gold standard of effective theraphy in MS (after the first year of treatment): No

MULTIPLE SCLEROSIS JOURNAL

SAGE PUBLICATIONS LTD

1. Bayer Schering Pharma
2. Biogen Idec
3. Genmab A/S
4. Merck Serono
5. Teva Pharmaceutical Industries Ltd.